Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Heliyon
|
September 13, 2023
Corrigendum to "Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus" [Heliyon 9(4) (April 2023) e15032]
Nancy E Hernandez, Wojciech Jankowski, Rahel Frick, et al.
Heliyon
|
April 10, 2023
Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus
Nancy E Hernandez, Wojciech Jankowski, Rahel Frick, et al.
Iscience
|
February 4, 2022
Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life
Algirdas Grevys, Rahel Frick, Simone Mester, et al.
JCI Insight
|
September 8, 2017
A TCRα framework-centered codon shapes a biased T cell repertoire through direct MHC and CDR3β interactions
Kristin Støen Gunnarsen, Lene Støkken Høydahl, Louise Fremgaard Risnes, et al.
Gastroenterology
|
December 30, 2018
Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease
Lene Støkken Høydahl, Lisa Richter, Rahel Frick, et al.
Science Immunology
|
August 21, 2021
A high-affinity human TCR-like antibody detects celiac disease gluten peptide-MHC complexes and inhibits T cell activation
Rahel Frick, Lene S Høydahl, Jan Petersen, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Heliyon
|
September 13, 2023
Corrigendum to "Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus" [Heliyon 9(4) (April 2023) e15032]
Nancy E Hernandez, Wojciech Jankowski, Rahel Frick, et al.
Heliyon
|
April 10, 2023
Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus
Nancy E Hernandez, Wojciech Jankowski, Rahel Frick, et al.
Iscience
|
February 4, 2022
Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life
Algirdas Grevys, Rahel Frick, Simone Mester, et al.
JCI Insight
|
September 8, 2017
A TCRα framework-centered codon shapes a biased T cell repertoire through direct MHC and CDR3β interactions
Kristin Støen Gunnarsen, Lene Støkken Høydahl, Louise Fremgaard Risnes, et al.
Gastroenterology
|
December 30, 2018
Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease
Lene Støkken Høydahl, Lisa Richter, Rahel Frick, et al.
Science Immunology
|
August 21, 2021
A high-affinity human TCR-like antibody detects celiac disease gluten peptide-MHC complexes and inhibits T cell activation
Rahel Frick, Lene S Høydahl, Jan Petersen, et al.
Page
of 2